Advertisement

Topics

WuXi and Gloria grant Arcus rights to anti-PD-1 antibody; deal worth up to $816mm

15:40 EDT 18 Aug 2017 | Elsevier Business Intelligence

Wuxi Biologics and partner Harbin Gloria Pharmaceuticals Co. Ltd. granted Arcus Biosciences Inc. exclusive rights to develop ...

Original Article: WuXi and Gloria grant Arcus rights to anti-PD-1 antibody; deal worth up to $816mm

NEXT ARTICLE

More From BioPortfolio on "WuXi and Gloria grant Arcus rights to anti-PD-1 antibody; deal worth up to $816mm"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...